Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoimmunity in visual loss.
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy.
New analysis shows Novartis drug Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
β-Amyloid: Enemy or Remedy?
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish.
EMD Serono Takes on Exclusive Promotion of Rebif® (interferon beta-1a) in the US
Role of regulatory b cells in neuroimmunologic disorders.
Teriflunomide for multiple sclerosis.
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta-1a in subjects with normal or impaired renal function.
Molecular characterization of a peripheral receptor for cannabinoids.
Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
Statement on a nonproprietary name adopted by the USAN Council
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Foxp3(+) Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production.
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review
NOVANTRONE. mitoXANTRONE for injection concentrate
Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.
Astrocyte-derived lactosylceramide implicated in multiple sclerosis.
Insight into the mechanism of laquinimod action.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.

Pages